Literature DB >> 16254367

Rational attenuation of a morbillivirus by modulating the activity of the RNA-dependent RNA polymerase.

David D Brown1, Bertus K Rima, Ingrid V Allen, Michael D Baron, Ashley C Banyard, Thomas Barrett, W Paul Duprex.   

Abstract

Negative-strand RNA viruses encode a single RNA-dependent RNA polymerase (RdRp) which transcribes and replicates the genome. The open reading frame encoding the RdRp from a virulent wild-type strain of rinderpest virus (RPV) was inserted into an expression plasmid. Sequences encoding enhanced green fluorescent protein (EGFP) were inserted into a variable hinge of the RdRp. The resulting polymerase was autofluorescent, and its activity in the replication/transcription of a synthetic minigenome was reduced. We investigated the potential of using this approach to rationally attenuate a virus by inserting the DNA sequences encoding the modified RdRp into a full-length anti-genome plasmid from which a virulent virus (rRPV(KO)) can be rescued. A recombinant virus, rRPV(KO)L-RRegfpR, which grew at an indistinguishable rate and to an identical titer as rRPV(KO) in vitro, was rescued. Fluorescently tagged polymerase was visible in large cytoplasmic inclusions and beneath the cell membrane. Subcutaneous injection of 10(4) TCID(50) of the rRPV(KO) parental recombinant virus into cattle leads to severe disease symptoms (leukopenia/diarrhea and pyrexia) and death by 9 days postinfection. Animals infected with rRPV(KO)L-RRegfpR exhibited transient leukopenia and mild pyrexia, and the only noticeable clinical signs were moderate reddening of one eye and a slight ocular-nasal discharge. Viruses that expressed the modified polymerase were isolated from peripheral blood lymphocytes and eye swabs. This demonstrates that a virulent morbillivirus can be attenuated in a single step solely by modulating RdRp activity and that there is not necessarily a correlation between virus growth in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254367      PMCID: PMC1280234          DOI: 10.1128/JVI.79.22.14330-14338.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Inhibition of in vitro leukocyte proliferation by morbilliviruses.

Authors:  J Heaney; T Barrett; S L Cosby
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV.

Authors:  Ulrike Schmidt; Jörg Beyer; Ulf Polster; Laurel J Gershwin; Ursula J Buchholz
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.

Authors:  M N Teng; S S Whitehead; P L Collins
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

4.  Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine.

Authors:  C K Ngichabe; H M Wamwayi; E K Ndungu; P K Mirangi; C J Bostock; D N Black; T Barrett
Journal:  Epidemiol Infect       Date:  2002-04       Impact factor: 2.451

5.  Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development.

Authors:  E B Flanagan; J M Zamparo; L A Ball; L L Rodriguez; G W Wertz
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  A transgenic mouse model for measles virus infection of the brain.

Authors:  G F Rall; M Manchester; L R Daniels; E M Callahan; A R Belman; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  Modulating the function of the measles virus RNA-dependent RNA polymerase by insertion of green fluorescent protein into the open reading frame.

Authors:  W Paul Duprex; Fergal M Collins; Bert K Rima
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses.

Authors:  Jason T Newman; Jeffrey M Riggs; Sonja R Surman; Josephine M McAuliffe; Teresa A Mulaikal; Peter L Collins; Brian R Murphy; Mario H Skiadopoulos
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host.

Authors:  Isidoro Martinez; Luis L Rodriguez; Carlos Jimenez; Steven J Pauszek; Gail W Wertz
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  A ferret model of canine distemper virus virulence and immunosuppression.

Authors:  Veronika von Messling; Christoph Springfeld; Patricia Devaux; Roberto Cattaneo
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more
  22 in total

1.  Domain structure of Lassa virus L protein.

Authors:  Linda Brunotte; Michaela Lelke; Meike Hass; Katja Kleinsteuber; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

2.  RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription.

Authors:  Thorsten Reuter; Benedikt Weissbrich; Sibylle Schneider-Schaulies; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus.

Authors:  D Silin; O Lyubomska; M Ludlow; W P Duprex; B K Rima
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

4.  Disease duration determines canine distemper virus neurovirulence.

Authors:  François Bonami; Penny A Rudd; Veronika von Messling
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

5.  Independent structural domains in paramyxovirus polymerase protein.

Authors:  Melanie Dochow; Stefanie A Krumm; James E Crowe; Martin L Moore; Richard K Plemper
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

6.  Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells.

Authors:  Subash C Das; Debasis Nayak; You Zhou; Asit K Pattnaik
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 7.  Development and application of reporter-expressing mononegaviruses: current challenges and perspectives.

Authors:  Darryl Falzarano; Allison Groseth; Thomas Hoenen
Journal:  Antiviral Res       Date:  2014-01-23       Impact factor: 5.970

8.  High-resolution functional profiling of the norovirus genome.

Authors:  Lucy Thorne; Dalan Bailey; Ian Goodfellow
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

9.  Generation and analysis of recombinant Bunyamwera orthobunyaviruses expressing V5 epitope-tagged L proteins.

Authors:  Xiaohong Shi; Richard M Elliott
Journal:  J Gen Virol       Date:  2009-02       Impact factor: 3.891

10.  Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist.

Authors:  D F Young; M C Galiano; K Lemon; Y-H Chen; J Andrejeva; W P Duprex; B K Rima; R E Randall
Journal:  J Gen Virol       Date:  2009-07-22       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.